Prognostic immune markers identifying patients with severe COVID-19 who respond to tocilizumab
Description
CONCLUSIONS: We found that tocilizumab has pleiotropic effects and that clinical response to this drug remain heterogenous. Our data suggest that it is possible to identify patients who will respond to treatment and that the administration of
